Gerrit-Anne Van Es

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

• Farooq V,
• Girasis C,
• Magro M,
• Onuma Y,
• Morel M-A,
• Heo J,
• García-García HM,
• Kappetein AP,
• van den Brand M,
• Holmes D,
• Mack M,
• Feldman T,
• Colombo A,
• Stahle E,
• James S,
• Carrié D,
• Fournial G,
• Van Es G-A,
• Dawkins K,
• Mohr F,
• Morice M-C,
• Serruys PW

EuroIntervention 2013;8:1277-1285 published online ahead of print August 2012

Published in Volume 8 Number 11, March 2013

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

• Kappetein AP,
• Head S,
• Généreux P,
• Piazza N,
• Van Mieghem N,
• Blackstone E,
• Brott T,
• Cohen D,
• Cutlip D,
• Van Es G-A,
• Hahn R,
• Kirtane A,
• Krucoff M,
• Kodali S,
• Mack M,
• Mehran R,
• Rodes-Cabau J,
• Vranckx P,
• Webb J,
• Windecker S,
• Serruys PW,
• Leon M

EuroIntervention 2012;8:782-795

Published in Volume 8 Number 7, November 2012

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

• Van Mieghem N,
• Head S,
• van der Boon R,
• Piazza N,
• de Jaegere P,
• Carrel T,
• Kappetein AP,
• Lange R,
• Walther T,
• Windecker S,
• Van Es G-A,
• Serruys PW

EuroIntervention 2012;8:258-266 publish online ahead of print March 2012

Published in Volume 8 Number 2, June 2012

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

• Vranckx P,
• Boersma E,
• Garg S,
• Valgimigli M,
• Van Es G-A,
• Goedhart D,
• Serruys PW

EuroIntervention 2011;7:859-871

Published in Volume 7 Number 7, November 2011

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

• Wykrzykowska J,
• Serruys PW,
• Buszman P,
• Linke A,
• Ischinger T,
• Klauss V,
• Eberli F,
• Corti R,
• Wijns W,
• Morice M-C,
• Di Mario C,
• van Geuns R-J,
• Van Es G-A,
• Jüni P,
• Windecker S

EuroIntervention 2011;7:789-795 publish online ahead of print October 2011

Published in Volume 7 Number 7, November 2011

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

• Wykrzykowska J,
• Garg S,
• Onuma Y,
• de Vries T,
• Morel M-A,
• Van Es G-A,
• Buszman P,
• Linke A,
• Ischinger T,
• Klauss V,
• Corti R,
• Eberli F,
• Wijns W,
• Morice M-C,
• Di Mario C,
• van Geuns R-J,
• Jüni P,
• Windecker S,
• Serruys PW

EuroIntervention 2011;7:605-613 publish online ahead of print June 2011

Published in Volume 7 Number 5, September 2011

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography

• Gutiérrez-Chico J-L,
• Räber L,
• Regar E,
• Okamura T,
• Di Mario C,
• Windecker S,
• Valgimigli M,
• Sabate M,
• von Birgelen C,
• Van Es G-A,
• Serruys PW

Published in Volume 7 Supplement M, May 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

• Sarno G,
• Garg S,
• Gomez-Lara J,
• García-García HM,
• Ligthart J,
• Bruining N,
• Onuma Y,
• Witberg K,
• van Geuns R-J,
• de Boer S,
• Wykrzykowska J,
• Schultz C,
• Duckers H,
• Regar E,
• de Jaegere P,
• de Feyter P,
• Van Es G-A,
• Boersma E,
• van der Giessen WJ,
• Serruys PW

EuroIntervention 2011;6:977-984

Published in Volume 6 Number 8, March 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

• Garg S,
• Wykrzykowska J,
• Serruys PW,
• de Vries T,
• Buszman P,
• Trznadel S,
• Linke A,
• Lenk K,
• Ischinger T,
• Klauss V,
• Eberli F,
• Corti R,
• Wijns W,
• Morice M-C,
• Di Mario C,
• Tyczynski P,
• van Geuns R-J,
• Eerdmans P,
• Van Es G-A,
• Meier B,
• Jüni P,
• Windecker S

EuroIntervention 2011;6:928-935

Published in Volume 6 Number 8, March 2011

Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation

• Piazza N,
• Nuis R,
• Tzikas A,
• Otten A,
• Onuma Y,
• García-García HM,
• Schultz C,
• van Domburg R,
• Van Es G-A,
• van Geuns R-J,
• de Jaegere P,
• Serruys PW

EuroIntervention 2010;6:475-484 published online ahead of print August 2010

Published in Volume 6 Number 4, September 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

• Garg S,
• Sarno G,
• Serruys PW,
• de Vries T,
• Buszman P,
• Linke A,
• Ischinger T,
• Klauss V,
• Eberli F,
• Corti R,
• Wijns W,
• Morice M-C,
• Di Mario C,
• van Geuns R-J,
• Eerdmans P,
• Van Es G-A,
• Meier B,
• Jüni P,
• Windecker S

EuroIntervention 2010;6:233-239

Published in Volume 6 Number 2, June 2010

Malapposed struts in drug-eluting stents entail higher risk of incomplete tissue coverage at 9- to 13-month follow-up compared to well-apposed struts: in vivo demonstration with optical coherence tomography

• Gutiérrez-Chico J-L,
• Regar E,
• Jüni P,
• Okamura T,
• García-García HM,
• Van Es G-A,
• Kelbaek H,
• Macaya C,
• Silber S,
• Di Mario C,
• Windecker S,
• Serruys PW

Published in Volume 6 Supplement H, May 2010

Implications of floating struts at side branches in the tissue coverage of drug-eluting stents at 9- to 13-months follow-up: in vivo assessment with optical coherence tomography

• Gutiérrez-Chico J-L,
• Regar E,
• Jüni P,
• Okamura T,
• García-García HM,
• Van Es G-A,
• Kelbaek H,
• Macaya C,
• Silber S,
• Di Mario C,
• Windecker S,
• Serruys PW

Published in Volume 6 Supplement H, May 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

• van Domburg R,
• Daemen J,
• Morice M-C,
• de Bruyne B,
• Colombo A,
• Macaya C,
• Richardt G,
• Fajadet J,
• Hamm C,
• Van Es G-A,
• Wittebols K,
• Macours N,
• Stoll H,
• Serruys PW

EuroIntervention 2010;5:962-967

Published in Volume 5 Number 8, April 2010

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

• García-García HM,
• Mintz G,
• Lerman A,
• Vince G,
• Margolis P,
• Van Es G-A,
• Morel M,
• Nair A,
• Virmani R,
• Burke A,
• Stone G,
• Serruys PW

EuroIntervention 2009;5:177-189

Published in Volume 5 Number 2, June 2009

The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer

• Garg S,
• Wykrzykowska J,
• de Vries T,
• Simon W,
• Buszman P,
• Trznadel S,
• Linke A,
• Lenk K,
• Ischinger T,
• Klauss V,
• Eberli F,
• Conti R,
• Wijns W,
• Morice M-C,
• Di Mario C,
• Davis S,
• van Geuns R-J,
• Eerdmans P,
• Van Es G-A,
• Meier B,
• Jüni P,
• Windecker S,
• Serruys PW

Published in Volume 5 Supplement E, May 2009

Assessment of the SYNTAX score in the Syntax study

• Serruys PW,
• Onuma Y,
• Garg S,
• Sarno G,
• van den Brand M,
• Kappetein AP,
• van Dyck N,
• Mack M,
• Holmes D,
• Feldman T,
• Morice M-C,
• Colombo A,
• Bass E,
• Leadley K,
• Dawkins K,
• Van Es G-A,
• Morel M-A,
• Mohr F

EuroIntervention 2009;5:50-56

Published in Volume 5 Number 1, May 2009

Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

• de Jaegere P,
• Piazza N,
• Galema T,
• Otten A,
• Soliman O,
• Van Dalen B,
• Geleijnse M,
• Kappetein AP,
• García-García HM,
• Van Es G-A,
• Serruys PW

EuroInterv.2008;4:351-357

Published in Volume 4 Number 3, November 2008

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

• Vranckx P,
• Kint P-P,
• Morel M-A,
• Van Es G-A,
• Serruys PW,
• Cutlip D

EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C39-C44

Published in Volume 4 Supplement C, August 2008

Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis

• García-García HM,
• Goedhart D,
• Schuurbiers JCH,
• Kukreja N,
• Tanimoto S,
• Daemen J,
• Morel M-A,
• Bressers M,
• Van Es G-A,
• Wentzel J,
• Gijsen F,
• van der Steen A,
• Serruys PW

EuroInterv.2006;2:338-344

Published in Volume 2 Number 3, November 2006